Charles River Laboratories (CRL) financial statements

+210.0%since 2008
FY2025 revenue
$4.0B▼ −0.9%
FY2025 net income
−$144M▼ −750.1%
FY2025 diluted EPS
−$2.91▼ −1,555.0%
FY2025 free cash flow
$518M▲ +3.4%

Charles River Laboratories income statement

Charles River Laboratories income statement
USD millionsFY2025FY2024FY2023
Period ended27 Dec 202528 Dec 202430 Dec 2023
Revenue4,0154,0504,129
Operating income25227617
Pretax income-10093581
Net income-14422475
Diluted earnings per share-2.910.209.22

Charles River Laboratories balance sheet

Charles River Laboratories balance sheet
USD millionsFY2025FY2024FY2023
Period ended27 Dec 202528 Dec 202430 Dec 2023
Cash and cash equivalents214206284
Total assets7,1357,5288,195
Total liabilities3,9244,0204,536
Total equity3,1703,4673,602
Long-term debt2,1362,2402,647

Charles River Laboratories cash flow statement

Charles River Laboratories cash flow statement
USD millionsFY2025FY2024FY2023
Period ended27 Dec 202528 Dec 202430 Dec 2023
Operating cash flow738735684
Capital expenditure-219-233-319
Free cash flow (derived)518502365
Share repurchases-361-119-24

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended26 Sep 202627 Jun 202628 Mar 202627 Dec 2025
Revenue (derived)9831,004996994
Operating income (derived)203120120-283
Net income (derived)333-1-15-277
Diluted earnings per share6.86-0.03-0.30n/a
Operating cash flow (derived)25418041148
Total assets7,4527,5327,7307,135

Charles River Laboratories major shareholders

Charles River Laboratories major shareholders
HolderShare of classSharesFiled
Abigail P. Johnson12.4%5,922,7555 November 2026
FMR LLC12.4%5,922,7555 November 2026
Vanguard Capital Management7.4%3,634,37630 April 2026
BlackRock, Inc.6.9%3,524,40117 April 2025
T. Rowe Price Associates, Inc.6.3%3,010,61916 November 2026

Charles River Laboratories 10-K and SEC filings

Charles River Laboratories 10-K and SEC filings
FiledFormTypeDescription
9 November 20268-KCurrent reportFORM 8-K
4 November 202610-QQuarterly reportQuarterly report
4 November 20268-KCurrent reportCurrent report
24 September 20268-KCurrent reportCurrent report
5 August 202610-QQuarterly reportQuarterly report
5 August 20268-KCurrent reportCurrent report
11 May 20268-KCurrent reportFORM 8-K
7 May 202610-QQuarterly reportQuarterly report

Common questions

What was Charles River Laboratories' revenue in fiscal 2025?

Charles River Laboratories reported $4.0 billion in revenue for fiscal 2025, the year ended 27 December 2025, down 0.9% from fiscal 2024.

What was Charles River Laboratories' net income in fiscal 2025?

Charles River Laboratories reported a net loss of $144 million for fiscal 2025, the year ended 27 December 2025. Diluted earnings per share were −$2.91.

What was Charles River Laboratories' free cash flow in fiscal 2025?

Charles River Laboratories had $518 million in free cash flow in fiscal 2025. Operating cash flow was $738 million and capital expenditure was $219 million.

What were Charles River Laboratories' total assets at the end of fiscal 2025?

Charles River Laboratories reported total assets of $7.1 billion at the end of fiscal 2025, the year ended 27 December 2025.

How much Charles River Laboratories history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.